Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN07Other nervous system drugs
- Pharmacological subgroupN07B
- Chemical subgroupN07BB
- Chemical substanceN07BB03Acamprosate
Where it is registered
Each register with its number of medicines and a few of them.
Netherlands
CBG-MEB · 4 medicines
- Campral 333 mg, maagsapresistente tablettenMaagsapresistente tablet · Euro Registratie Collectief B.V.
- Campral 333 mg, maagsapresistente tablettenMaagsapresistente tablet · Medcor Pharmaceuticals B.V.
- Campral, maagsapresistente tabletten 333 mgMaagsapresistente tablet · Merck B.V.
- Campral, maagsapresistente tabletten 333 mgMaagsapresistente tablet · Originalis B.V.
Serbia
ALIMS · 2 medicines
United States
FDA · 2 medicines
Brazil
Anvisa · 1 medicine · Historical list
Canada
Health Canada · 1 medicine
Spain
AEMPS · 1 medicine
Italy
AIFA · 1 medicine
Taiwan
TFDA · 1 medicine · Historical list
All medicines with Acamprosate
Every register, a page at a time. Strengths and packs are on each medicine’s page.
13 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Acamprosate Calcium | United States | 333MG | tablet, delayed release | Marketed | Glenmark Pharms LTD |
| Campral | United States | 333MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, delayed release | Not marketed | Forest Labs |
| Campral | Italy | Compressa gastroresistente | Authorised | Bruno Farmaceutici S.P.A. | |
| Campral | Canada | 333 MG | Tablet (Delayed-Release) | Marketed | Mylan Pharmaceuticals Ulc |
| CAMPRAL 333 mg COMPRIMIDOS RECUBIERTOS | Spain | 333 mg | comprimido recubierto | Marketed | Merck Sante |
| Campral 333 mg, maagsapresistente tabletten | Netherlands | Maagsapresistente tablet | Authorised | Euro Registratie Collectief B.V. | |
| Campral 333 mg, maagsapresistente tabletten | Netherlands | Maagsapresistente tablet | Authorised | Medcor Pharmaceuticals B.V. | |
| Campral, maagsapresistente tabletten 333 mg | Netherlands | Maagsapresistente tablet | Authorised | Originalis B.V. | |
| Campral, maagsapresistente tabletten 333 mg | Netherlands | Maagsapresistente tablet | Authorised | Merck B.V. | |
| Campral® | Serbia | 333mg | gastrorezistentna tableta | Authorised | Merck D.O.O. Beograd |
| Campral® | Serbia | 333mg | gastrorezistentna tableta | Authorised | Merck D.O.O. Beograd |
| Campral | Brazil | Cancelled | Merck S/A | ||
| ALGLUTOL 333 mg Delayed-Release Tablets | Taiwan | 腸溶錠 | Expired | 美時化學製藥股份有限公司 |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
- Merck D.o.o. Beograd2 medicines
- Euro Registratie Collectief B.V.1 medicine
- Merck Sante s.a.s.1 medicine
- 美時化學製藥股份有限公司1 medicine
- Originalis B.V.1 medicine
- Forest Labs1 medicine
- Medcor Pharmaceuticals B.V.1 medicine
- Mylan Pharmaceuticals Ulc1 medicine
- Merck B.V.1 medicine
- Merck S/A1 medicine
- Glenmark Pharmaceuticals Limited1 medicine
- BRUNO FARMACEUTICI SpA1 medicine
Names in the registers
How the registers write it, in their own languages.
- Acamprosaat
- Acamprosato
- Akamprosat
Sources
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, Health Canada and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- ATC code
- N07BB03
- ATC group
- Nervous system
- Registers
- 8
- Medicines
- 13
- Companies
- 12